STOCKHOLDERS' EQUITY (Details 3) (USD $)	3 Months Ended	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2012		Dec. 31, 2011
Options Exercised		1,931,788
Company Options
Balance Beginning		10,590,161
Awards Granted	562,422	5,121,250	[1]	10,682,218	[1]
Options Exercised		(1,931,788)		(92,057)
Expired
Cancelled		(46,135)
Balance ending	10,590,161	13,733,488		10,590,161
Vested and exercisable		8,370,408
Exercise Price		$ 0.16		$ 0.16
Granted		$ 2.80		$ 0.19
Exercised		$ 0.13
Cancelled
Exercise Price	$ 0.16	$ 1.16		$ 0.16
Vested and exercisable		$ 0.38
Weighted Average Remaining Contractual Life
Balance Beginning		7 years 7 months 6 days
Granted		9 years 8 months 12 days		7 years 7 months 6 days
Balance ending	7 years 7 months 6 days	7 years 8 months 12 days		7 years 7 months 6 days
Vested and exercisable		6 years 8 months 12 days
Balance Beginning		$ 14,067,649
Granted		$ 1,737,530		$ 14,188,484
Balance ending	14,067,649	26,804,117		14,067,649
Vested and exercisable		$ 22,811,422

[1] This includes: (i) VitaMed Options granted between October 2008 and December 31, 2010 for an aggregate of 7,639,722 Units of which 16,000 were canceled prior to conversion (or Company Options for 9,357,561 shares per the Conversion Ratio), (ii) VitaMed Options granted between January 1, 2011 and October 3, 2011 for an aggregate of 621,000 Units (or Company Options for 762,235 shares per the Conversion Ratio) and (iii) Company Options granted between October 4, 2011 and December 31, 2011 for an aggregate of 562,422 shares. The terms and conditions of the VitaMed Options were reflected in the replacement Company Options including the number of shares vested.